Literature DB >> 4465472

Halothane hepatitis with renal failure treated with hemodialysis and exchange transfusion.

M Ishikawa, M M Popovtzer, S Iwatsuki, T Johansen, T E Starzl.   

Abstract

A 38-year-old white female, hepatitis B antigen negative, developed fluminating hepatic failure associated with oliguria and severe azotemia after two halothane anesthesia and without exposure to other hepatotoxic drugs or blood transfusions. She was treated with multiple hemodialysis and exchange blood transfusion. The combined treatment corrected the uremic abnormalities and improved her level of consciousness. the liver and kidney function gradually improved, and she made a complete recovery, the first recorded with hepatic and renal failure under these postanesthetic conditions. Further evaluation of this combined treatment used for this patient is warranted.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4465472      PMCID: PMC2966302          DOI: 10.1007/bf02469454

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  9 in total

1.  TREATMENT OF HEPATIC COMA BY HEMODIALYSIS.

Authors:  J G WEG; R E HARRIS; M B MILLER; D S WILTSIE; J J MCPHAUL; M FINKEL
Journal:  Tex State J Med       Date:  1964-09

2.  Halothane jaundice andhepatotoxicity.

Authors:  F J TORNETTA; H T TAMAKI
Journal:  JAMA       Date:  1963-05-25       Impact factor: 56.272

3.  Ammonia intoxication treated by hemodialysis.

Authors:  J E KILEY; J C PENDER; H F WELCH; C S WELCH
Journal:  N Engl J Med       Date:  1958-12-11       Impact factor: 91.245

Review 4.  Halothane hepatitis: a critical review.

Authors:  F M Carney; R A Van Dyke
Journal:  Anesth Analg       Date:  1972 Jan-Feb       Impact factor: 5.108

5.  Controlled trial of exchange-transfusion therapy in fulminant hepatitis.

Authors:  A G Redeker; H S Yamahiro
Journal:  Lancet       Date:  1973-01-06       Impact factor: 79.321

Review 6.  Haemodialysis in the treatment of liver failure.

Authors:  W M Keynes
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

7.  The fulminant hepatic failure surveillance study. Brief review of the effects of presumed etiology and age of survival.

Authors:  C Trey
Journal:  Can Med Assoc J       Date:  1972-02-26       Impact factor: 8.262

8.  Hepatic necrosis associated with halothane anesthesia.

Authors:  R L Peters; H A Edmondson; T B Reynolds; J C Meister; T J Curpey
Journal:  Am J Med       Date:  1969-11       Impact factor: 4.965

9.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10-1970.

Authors: 
Journal:  N Engl J Med       Date:  1970-03-05       Impact factor: 91.245

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.